Back to Authors

Sahin‐Tóth, Miklós

https://orcid.org/0000-0003-4513-9922

A5065614760 | I111088046

Mayo Clinic

Boston University

Citations 1

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers

Oncotarget | October 4, 2015 | Volume: 6 | Issue: 34 | Pages: 35737-35754

10.18632/oncotarget.5927 | PMID 26437224